Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
Identifieur interne : 000403 ( Main/Corpus ); précédent : 000402; suivant : 000404Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
Auteurs : Gianluca Vanni ; Marco Pellicciaro ; Marco Materazzo ; Valentina Bruno ; Chiara Oldani ; Chiara Adriana Pistolese ; Chiara Buonomo ; Jonathan Caspi ; Paola Gualtieri ; Agostino Chiaravalloti ; Leonardo Palombi ; Emilio Piccione ; Oreste Claudio BuonomoSource :
- In vivo (Athens, Greece) [ 1791-7549 ]
English descriptors
- KwdEn :
- Aged (MeSH), Betacoronavirus (pathogenicity), Breast Neoplasms (complications), Breast Neoplasms (diagnosis), Breast Neoplasms (epidemiology), Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Coronavirus Infections (virology), Early Detection of Cancer (MeSH), Female (MeSH), Humans (MeSH), Mammography (MeSH), Mass Screening (trends), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Pneumonia, Viral (virology).
- MESH :
- complications : Breast Neoplasms, Coronavirus Infections, Pneumonia, Viral.
- diagnosis : Breast Neoplasms.
- epidemiology : Breast Neoplasms, Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- trends : Mass Screening.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Aged, Early Detection of Cancer, Female, Humans, Mammography, Middle Aged, Pandemics.
Abstract
BACKGROUND/AIM
Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.
PATIENTS AND METHODS
Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.
RESULTS
Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.
CONCLUSION
Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.
DOI: 10.21873/invivo.12139
PubMed: 32871851
Links to Exploration step
pubmed:32871851Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.</title><author><name sortKey="Vanni, Gianluca" sort="Vanni, Gianluca" uniqKey="Vanni G" first="Gianluca" last="Vanni">Gianluca Vanni</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pellicciaro, Marco" sort="Pellicciaro, Marco" uniqKey="Pellicciaro M" first="Marco" last="Pellicciaro">Marco Pellicciaro</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Materazzo, Marco" sort="Materazzo, Marco" uniqKey="Materazzo M" first="Marco" last="Materazzo">Marco Materazzo</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Bruno, Valentina" sort="Bruno, Valentina" uniqKey="Bruno V" first="Valentina" last="Bruno">Valentina Bruno</name><affiliation><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Oldani, Chiara" sort="Oldani, Chiara" uniqKey="Oldani C" first="Chiara" last="Oldani">Chiara Oldani</name><affiliation><nlm:affiliation>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pistolese, Chiara Adriana" sort="Pistolese, Chiara Adriana" uniqKey="Pistolese C" first="Chiara Adriana" last="Pistolese">Chiara Adriana Pistolese</name><affiliation><nlm:affiliation>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Buonomo, Chiara" sort="Buonomo, Chiara" uniqKey="Buonomo C" first="Chiara" last="Buonomo">Chiara Buonomo</name><affiliation><nlm:affiliation>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Caspi, Jonathan" sort="Caspi, Jonathan" uniqKey="Caspi J" first="Jonathan" last="Caspi">Jonathan Caspi</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Gualtieri, Paola" sort="Gualtieri, Paola" uniqKey="Gualtieri P" first="Paola" last="Gualtieri">Paola Gualtieri</name><affiliation><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Chiaravalloti, Agostino" sort="Chiaravalloti, Agostino" uniqKey="Chiaravalloti A" first="Agostino" last="Chiaravalloti">Agostino Chiaravalloti</name><affiliation><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Palombi, Leonardo" sort="Palombi, Leonardo" uniqKey="Palombi L" first="Leonardo" last="Palombi">Leonardo Palombi</name><affiliation><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Piccione, Emilio" sort="Piccione, Emilio" uniqKey="Piccione E" first="Emilio" last="Piccione">Emilio Piccione</name><affiliation><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Buonomo, Oreste Claudio" sort="Buonomo, Oreste Claudio" uniqKey="Buonomo O" first="Oreste Claudio" last="Buonomo">Oreste Claudio Buonomo</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Sep-Oct</date><idno type="RBID">pubmed:32871851</idno><idno type="pmid">32871851</idno><idno type="doi">10.21873/invivo.12139</idno><idno type="wicri:Area/Main/Corpus">000403</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000403</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.</title><author><name sortKey="Vanni, Gianluca" sort="Vanni, Gianluca" uniqKey="Vanni G" first="Gianluca" last="Vanni">Gianluca Vanni</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pellicciaro, Marco" sort="Pellicciaro, Marco" uniqKey="Pellicciaro M" first="Marco" last="Pellicciaro">Marco Pellicciaro</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Materazzo, Marco" sort="Materazzo, Marco" uniqKey="Materazzo M" first="Marco" last="Materazzo">Marco Materazzo</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Bruno, Valentina" sort="Bruno, Valentina" uniqKey="Bruno V" first="Valentina" last="Bruno">Valentina Bruno</name><affiliation><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Oldani, Chiara" sort="Oldani, Chiara" uniqKey="Oldani C" first="Chiara" last="Oldani">Chiara Oldani</name><affiliation><nlm:affiliation>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Pistolese, Chiara Adriana" sort="Pistolese, Chiara Adriana" uniqKey="Pistolese C" first="Chiara Adriana" last="Pistolese">Chiara Adriana Pistolese</name><affiliation><nlm:affiliation>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Buonomo, Chiara" sort="Buonomo, Chiara" uniqKey="Buonomo C" first="Chiara" last="Buonomo">Chiara Buonomo</name><affiliation><nlm:affiliation>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Caspi, Jonathan" sort="Caspi, Jonathan" uniqKey="Caspi J" first="Jonathan" last="Caspi">Jonathan Caspi</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Gualtieri, Paola" sort="Gualtieri, Paola" uniqKey="Gualtieri P" first="Paola" last="Gualtieri">Paola Gualtieri</name><affiliation><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Chiaravalloti, Agostino" sort="Chiaravalloti, Agostino" uniqKey="Chiaravalloti A" first="Agostino" last="Chiaravalloti">Agostino Chiaravalloti</name><affiliation><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Palombi, Leonardo" sort="Palombi, Leonardo" uniqKey="Palombi L" first="Leonardo" last="Palombi">Leonardo Palombi</name><affiliation><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Piccione, Emilio" sort="Piccione, Emilio" uniqKey="Piccione E" first="Emilio" last="Piccione">Emilio Piccione</name><affiliation><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Buonomo, Oreste Claudio" sort="Buonomo, Oreste Claudio" uniqKey="Buonomo O" first="Oreste Claudio" last="Buonomo">Oreste Claudio Buonomo</name><affiliation><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation></affiliation></author></analytic><series><title level="j">In vivo (Athens, Greece)</title><idno type="eISSN">1791-7549</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Betacoronavirus (pathogenicity)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (diagnosis)</term><term>Breast Neoplasms (epidemiology)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (virology)</term><term>Early Detection of Cancer (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Mammography (MeSH)</term><term>Mass Screening (trends)</term><term>Middle Aged (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (virology)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Early Detection of Cancer</term><term>Female</term><term>Humans</term><term>Mammography</term><term>Middle Aged</term><term>Pandemics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND/AIM</b></p><p>Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.</p></div><div type="abstract" xml:lang="en"><p><b>PATIENTS AND METHODS</b></p><p>Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32871851</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1791-7549</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>5</Issue><PubDate><MedlineDate>2020 Sep-Oct</MedlineDate></PubDate></JournalIssue><Title>In vivo (Athens, Greece)</Title><ISOAbbreviation>In Vivo</ISOAbbreviation></Journal><ArticleTitle>Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.</ArticleTitle><Pagination><MedlinePgn>3047-3053</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21873/invivo.12139</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.</AbstractText><CopyrightInformation>Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vanni</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicciaro</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Materazzo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruno</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oldani</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistolese</LastName><ForeName>Chiara Adriana</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonomo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caspi</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gualtieri</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiaravalloti</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palombi</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccione</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonomo</LastName><ForeName>Oreste Claudio</ForeName><Initials>OC</Initials><AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>In Vivo</MedlineTA><NlmUniqueID>8806809</NlmUniqueID><ISSNLinking>0258-851X</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="Y">Early Detection of Cancer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008327" MajorTopicYN="N">Mammography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-SOV-2</Keyword><Keyword MajorTopicYN="N">breast cancer</Keyword><Keyword MajorTopicYN="N">breast cancer screening</Keyword><Keyword MajorTopicYN="N">early diagnosis</Keyword><Keyword MajorTopicYN="N">local advanced diagnosis</Keyword><Keyword MajorTopicYN="N">mammography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32871851</ArticleId><ArticleId IdType="pii">34/5/3047</ArticleId><ArticleId IdType="doi">10.21873/invivo.12139</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000403 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000403 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32871851
|texte= Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32871851" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |